# Polymyxin B Monotherapy vs Combination Therapy in Critically Ill Patients With Multi-drug Resistant Pathogens

> **NCT03159078** · PHASE3 · UNKNOWN · sponsor: **University of Puerto Rico** · enrollment: 40 (estimated)

## Conditions studied

- Trauma
- Resistant Infection
- Critical Illness

## Interventions

- **DRUG:** Polymyxin B

## Key facts

- **NCT ID:** NCT03159078
- **Lead sponsor:** University of Puerto Rico
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-25
- **Primary completion:** 2019-12-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03159078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03159078, "Polymyxin B Monotherapy vs Combination Therapy in Critically Ill Patients With Multi-drug Resistant Pathogens". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03159078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*